BXRXQ — Baudax Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $13.91m
- $1.27m
U.S. RESEARCH ROUNDUP-Crowdstrike, LPL Financial, Signify Health
U.S. STOCKS ON THE MOVE-Best Buy, Mosaic, Getty Images, Big Lots
U.S. STOCKS ON THE MOVE-Arbutus, Trimble, Hempacco
U.S. STOCKS ON THE MOVE-Opera, Chinese ADRs, IN8bio
U.S. STOCKS ON THE MOVE-Freyr Battery, IQIYI, First Solar
Baudax Bio sinks on $6.2 million public offering
Brief: Baudax Bio Announces Pricing Offering Of Aggregate Of 11.8 Million Shares Of Common Stock & Accompanying Common Stock Purchase Warrants At $0.525 Per Share
Brief: Baudax Bio Receives Notice Of Allowance For U.S. Patent Application Covering Use Of Anjeso For Treatment Of Moderate To Severe Pain
Brief: Baudax Bio Reports Second Quarter 2022 Financial Results And Business Highlights
Baudax Bio Inc expected to post a loss of $1.27 a share - Earnings Preview
Brief: Baudax Bio Says Received Deficiency Letter From Staff Of Nasdaq
Brief: Baudax Bio Announces Dosing Of First Cohort In First-In-Man, Phase I Clinical Study Evaluating BX2000
U.S. STOCKS ON THE MOVE-Target, Surrozen, Agilysys, Carvana
U.S. STOCKS ON THE MOVE-Prenetics Ltd, BlackBerry Ltd, TJX Cos Inc
U.S. STOCKS ON THE MOVE-Sea Ltd, Tesla Inc, TJX Cos Inc
Baudax Bio falls on $2 mln equity offering
Brief: Baudax Bio Announces $2 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Baudax Bio Inc reports results for the quarter ended in March - Earnings Summary
Brief: Baudax Bio Says Chairman Alfred Altomari Notified Of His Intent To Resign From Board